Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine.
1988
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss
2000
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report
2007
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
2005
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Liposomes, a promising strategy for clinical application of platinum derivatives
2013
Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study
2008
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Molecular mechanisms of drug resistance
2005
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
2002
Cancer Metastasis: Building a Framework
2006 Standout
Chemotactic peptides
1988
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk
2000
Genomic instability in Ip and human malignancies
1996
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Crohn's disease--a permeability disorder of the tight junction?
1988
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
2003
Notch signaling in neuroblastoma
2004
Malignant rhabdoid tumor: A highly malignant childhood tumor with minimal karyotypic changes
1990
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 StandoutNature
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Intestinal permeability in gastrointestinal disorders
1990
Increased Intestinal Permeability to (51 Cr) EDTA Is Correlated with IgA Immune Complex‐Plasma Levels in Children with IgA‐Associated Nephropathies
1988
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2
2003
Nanocarriers for delivery of platinum anticancer drugs
2013
Metagenomic biomarker discovery and explanation
2011 Standout
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
2007
Inflammatory Bowel Disease
1991 Standout
Medulloblastoma in childhood: new biological advances
2007
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
1993
Intestinal permeability during chemotherapy for childhood tumours
1988
High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma
2005
Intestinal mucosal barrier function in health and disease
2009 Standout
Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan
2001
Malignant Gliomas in Adults
2008 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Comprehensive analysis of chromosome 1p deletions in neuroblastoma
2001
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
1999 StandoutNobel
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
2005
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
2000
Intestinal permeability and the prediction of relapse in Crohn's disease
1993
Application of liposomal technologies for delivery of platinum analogs in oncology
2013
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Neuroblastoma
2007 Standout
Malignant rhabdoid tumor of the kidney: Involvement of chromosome 22
1994
Targeted Epithelial Tight Junction Dysfunction Causes Immune Activation and Contributes to Development of Experimental Colitis
2008
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
2002
Intestinal permeability: An overview
1995
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1998 StandoutNature
Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine
2007
Variety and complexity of chromosome 17 translocations in neuroblastoma
2003
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Mechanism and relevance of ploidy in neuroblastoma
2000
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
Genetic parameters of neuroblastomas
2002
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
The tumore suppressor p53
1993
Brain Tumors
2001 Standout
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
2010
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Intestinal permeability.
1994
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion.
1991
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
2000
A cancer family syndrome in twenty-four kindreds.
1988
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
PPM1D is a potential target for 17q gain in neuroblastoma.
2003
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors
2003
Magnesium in Man: Implications for Health and Disease
2014 Standout
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.
2001
Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a−/− mice
2005
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Mechanisms of DNA Excision Repair
1994 StandoutScienceNobel
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
Cancer Cell Cycles
1996 StandoutScience
High-dose rapid schedule chemotherapy for disseminated neuroblastoma
1992
Excess risk of breast cancer in the mothers of children with soft tissue sarcomas
1984
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
2005
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 StandoutScience
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
THE LEAKY GUT OF ALCOHOLISM: POSSIBLE ROUTE OF ENTRY FOR TOXIC COMPOUNDS
1984
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
1995 Standout
The Origins of Medulloblastoma Subtypes
2008
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
2003
Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group Study
2000
Molecular Biology of Neuroblastoma
1999
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
1999
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non‐invasive differential sugar permeation
1986
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system
2006
Increased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives
1986
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
Intestinal permeability in patients with Crohn's disease and their first degree relatives.
1992
Works of A D Pearson being referenced
Clinical and molecular stratification of disease risk in medulloblastoma
2001
Dose-related nephrotoxicity of carboplatin in children
1999
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma
1995
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
1999
Mitotic percentage index: a new prognostic factor for childhood medulloblastoma
1997
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours
1992
Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears
1994
Conduct of phase I trials in children with cancer.
1998
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group.
1993
A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin
2001
Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.
1991
Improved method for immunoperoxidase detection of membrane antigens in frozen sections.
1989
Investigation of coamplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a dead box gene, DDX1, in neuroblastoma
1996
Two families with the Li-Fraumeni cancer family syndrome
1982
Intestinal permeability in Crohn's disease.
1989
Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
1999
Temozolomide in Malignant Gliomas of Childhood: A United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study
2002
Small bowel function in acute lymphoblastic leukaemia.
1984
Intestinal permeability in children with Crohn's disease and coeliac disease.
1982
Cytogenetic studies of childhood solid tumors
1989
Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.
1993